(d(CH2)₅¹,D-Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin

(2S)-N-[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(10R,13S,16S,19S,22R)-13-(2-amino-2-oxoethyl)-19-benzyl-22-[(4-ethoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-16-propan-2-yl-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carbonyl]pyrrolidine-2-carboxamide

LS-186846; Mcp-tva-argipressin; SKF 101926; β-Mercapto-β,β-cyclopentamethylene-propionyl-D-Tyr(Et)-Phe-Val-Asn-Cys-Pro-Arg-NH2 (Disulfide bond); d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP; 1-((β-Mercapto-β)β-cyclopentamethylenepropionic acid)-2-(O-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin; 1-{[(10R,13S,16S,19S,22R)-13-(2-Amino-2-oxoethyl)-19-benzyl-22-(4-ethoxybenzyl)-16-isopropyl-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentaazaspiro[5.19]pentacos-10-yl]carbonyl}-L-prolyl-N5-(diaminomethylene)-L-ornithinamide; N-[[1-Mercapto(1)-cyclohexyl]acetyl]-O-ethyl-D-Tyr-L-Phe-L-Val-L-Asn-L-Cys(1)-L-Pro-L-Arg-NH2; O-Ethyl-N-[1-mercapto(1)cyclohexylacetyl]-D-Tyr-L-Phe-L-Val-L-Asn-L-Cys(1)-L-Pro-L-Arg-NH2; (d(CH2)51,D-Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin

White Powder

95%

1.43±0.1 g/cm3

Store at -20°C

Hormone Antagonists

InChI=1S/C51H74N12O10S2/c1-4-73-33-19-17-32(18-20-33)26-35-44(67)59-36(25-31-13-7-5-8-14-31)46(69)62-42(30(2)3)48(71)60-37(27-40(52)64)45(68)61-38(29-74-75-51(28-41(65)57-35)21-9-6-10-22-51)49(72)63-24-12-16-39(63)47(70)58-34(43(53)66)15-11-23-56-50(54)55/h5,7-8,13-14,17-20,30,34-39,42H,4,6,9-12,15-16,21-29H2,1-3H3,(H2,52,64)(H2,53,66)(H,57,65)(H,58,70)(H,59,67)(H,60,71)(H,61,68)(H,62,69)(H4,54,55,56)/t34-,35+,36-,37-,38-,39-,42-/m0/s1

DRLYXDZRLDZVIS-XXNQTUAPSA-N

CCOC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSC3(CCCCC3)CC(=O)N2)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)N)CC(=O)N)C(C)C)CC5=CC=CC=C5